Back

Effect of transcatheter aortic valve implantation (TAVI) in acquired von Willebrand syndrome and molecular analysis of high-molecular-weight multimers.

26 August 2017 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Risk stratification and prognosis after TAVI Aortic valve disease ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Marco Alfonso Perrone

Tor Vergata University Hospital Polyclinic, Rome (Italy)

10 More presentations in this session

Presentation thumbnail
Doctor H. Hioki (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Doctor F. Jansen (Cologne, DE)
Abstract Slides
Presentation thumbnail
Mrs A. Stundl (Bonn, DE)
Abstract Slides
Presentation thumbnail
Mrs A. Stundl (Bonn, DE)
Abstract Slides
Presentation thumbnail
Professor R. Waksman (Washington, DC, US)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Risk stratification and prognosis after TAVI

The Event

Event poster

ESC Congress 2017

26 August 2017 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources